Table 5.
Stability* (%) | |
---|---|
3-HPG | - |
Val-3-HPG (5a) | 86.5 ± 0.3 |
Ile-3-HPG (5b) | 96.6 ± 0.6 |
Phe-3-HPG (5c) | 3.9 ± 2.0 |
D-Val-3-HPG (5d) | 98.8 ± 0.1 |
valacyclovir | 94.7 ± 0.3 |
percentage of ester form in donor solution at 120 min
Stability* (%) | |
---|---|
3-HPG | - |
Val-3-HPG (5a) | 86.5 ± 0.3 |
Ile-3-HPG (5b) | 96.6 ± 0.6 |
Phe-3-HPG (5c) | 3.9 ± 2.0 |
D-Val-3-HPG (5d) | 98.8 ± 0.1 |
valacyclovir | 94.7 ± 0.3 |
percentage of ester form in donor solution at 120 min